MARSHALL WACE, LLP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in ANIK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$346,999

-$490,877 QoQ

Shares Held

23,931

-72.6% QoQ

Ownership

0.180%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. ANIK ranks #27 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	9,349,817	$126,316,026
2	NBIX	Neurocrine Biosciences Inc	508,977	$67,052,628
3	LNTH	Lantheus Holdings, Inc.	611,747	$46,401,008
4	UTHR	UNITED THERAPEUTICS Corp	75,977	$45,052,841
5	RDY	Dr Reddys Laboratories Ltd	2,664,306	$36,900,638
6	ALKS	Alkermes plc.	999,322	$35,336,024
7	ELAN	Elanco Animal Health Inc	1,382,412	$33,081,118
8	COLL	Collegium Pharmaceutical, Inc	748,812	$24,763,212

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$346,999	23,931	-72.6%	Shares	Other	2026-05-15
2025-12-31	$837,876	87,188	+18.3%	Shares	Other	2026-02-13
2025-09-30	$693,005	73,724	+223.6%	Shares	Other	2025-11-13
2025-06-30	$241,033	22,782	+118.5%	Shares	Other	2025-08-13
2024-12-31	$171,611	10,426	-36.4%	Shares	Other	2025-02-13
2024-09-30	$404,610	16,381	-41.1%	Shares	Other	2024-11-14
2024-06-30	$704,528	27,814	-18.9%	Shares	Other	2024-08-14
2024-03-31	$871,016	34,292	+66.7%	Shares	Other	2024-05-15
2023-12-31	$466,161	20,572	+29.8%	Shares	Other	2024-02-14
2022-12-31	$469,012	15,845	-65.8%	Shares	Other	2023-02-14
2022-06-30	$1,034,375	46,343	+386.0%	Shares	Other	2022-08-15
2021-09-30	$405,852	9,536	-28.7%	Shares	Sole	2021-11-15
2021-03-31	$545,892	13,383	+116.7%	Shares	Sole	2021-05-17
2020-03-31	$178,577	6,177	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.